RNF103 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.802200E-01
Normal-vs-Stage2
2.284200E-01
Normal-vs-Stage3
6.635000E-01
Normal-vs-Stage4
4.031600E-02
Stage1-vs-Stage2
6.101200E-01
Stage1-vs-Stage3
9.931800E-01
Stage1-vs-Stage4
8.295600E-02
Stage2-vs-Stage3
6.935400E-01
Stage2-vs-Stage4
8.060000E-02
Stage3-vs-Stage4
3.163200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.681000E-01
Normal-vs-AfricanAmerican
1.096850E-01
Normal-vs-Asian
1.996610E-01
Caucasian-vs-AfricanAmerican
9.644200E-01
Caucasian-vs-Asian
1.794630E-01
AfricanAmerican-vs-Asian
4.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.322600E-01
Normal-vs-Female
2.670000E-01
Male-vs-Female
3.927200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.626600E-01
Normal-vs-Age(41-60Yrs)
1.635210E-01
Normal-vs-Age(61-80Yrs)
2.910400E-01
Normal-vs-Age(81-100Yrs)
2.783400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.745600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.382600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.636000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.320000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.206000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.595800E-01
Normal-vs-Daily Drinker
4.566600E-01
Normal-vs-Weekly Drinker
5.577200E-01
Normal-vs-Occasional Drinker
1.236190E-01
Normal-vs-Social Drinker
1.061640E-01
Non Drinker-vs-Daily Drinker
3.058400E-01
Non Drinker-vs-Weekly Drinker
9.198000E-01
Non Drinker-vs-Occasional Drinker
1.444450E-01
Non Drinker-vs-Social Drinker
4.513800E-01
Daily Drinker-vs-Weekly Drinker
6.590000E-01
Daily Drinker-vs-Occasional Drinker
2.727600E-02
Daily Drinker-vs-Social Drinker
6.277000E-01
Weekly Drinker-vs-Occasional Drinker
3.160000E-01
Weekly Drinker-vs-Social Drinker
8.124400E-01
Occasional Drinker-vs-Social Drinker
4.733800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.098300E-02
Normal-vs-Grade 2
8.198300E-03
Normal-vs-Grade 3
2.164100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.928110E-02
Grade 1-vs-Grade 3
1.196980E-01
Grade 1-vs-Grade 4
2.098300E-02
Grade 2-vs-Grade 3
5.200200E-01
Grade 2-vs-Grade 4
8.198300E-03
Grade 3-vs-Grade 4
2.164100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.780600E-01
Normal-vs-NonDiabetic
2.042600E-01
Diabetic-vs-NonDiabetic
2.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.243600E-01
Normal-vs-NoPancreatitis
2.807000E-01
Pancreatitis-vs-NoPancreatitis
5.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.635230E-01
Normal-vs-N1
2.611400E-01
N0-vs-N1
7.506600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.132780E-01
Normal-vs-TP53-NonMutant
2.470000E-01
TP53-Mutant-vs-TP53-NonMutant
1.323190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
